Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Sartor · SciRah

Researcher profile · Semantic Scholar

C. Sartor

Share profile

C. Sartor — researcher profile on SciRah

h-index: 20
Works: 150
Citations: 1,505

Most-cited papers

β-catenin-activated hepatocellular carcinomas are addicted to fatty acids
Nadia Senni, M. Savall, David Cabrerizo Granados, M. Alves-Guerra +8 more
2018Gut139 citations
Semantic Scholar
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia
G. Martinelli, C. Papayannidis, A. Piciocchi, V. Robustelli +34 more
2021Blood Advances70 citations Open access
Semantic Scholar
First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
G. Martinelli, A. Piciocchi, C. Papayannidis, S. Paolini +31 more
201761 citations
Semantic Scholar
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
Andrea Ghelli Luserna di Rorá, N. Beeharry, Enrica Imbrogno, A. Ferrari +20 more
2018Journal of Hematology & Oncology42 citations Open access
Semantic Scholar
Hepatocellular Carcinomas With Mutational Activation of Beta Catenin Require Choline and can be Detected by Positron Emission Tomography.
Angélique Gougelet, C. Sartor, Nadia Senni, J. Calderaro +14 more
2019Gastroenterology35 citations Open access
Semantic Scholar
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin
S. Kayser, C. Sartor, Marlise R. Luskin, Jonathan A. Webster +10 more
2022Haematologica27 citations Open access
Semantic Scholar
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with Venetoclax
A. Candoni, D. Lazzarotto, C. Papayannidis, M. Piccini +28 more
2023American journal of hematology/oncology25 citations Open access
Semantic Scholar
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia
S. Ragaini, S. Wagner, G. Marconi, S. Parisi +15 more
2021Blood Advances25 citations Open access
Semantic Scholar
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
Andrea Ghelli Luserna di Rorá, M. Bocconcelli, A. Ferrari, C. Terragna +14 more
2019Cancers25 citations Open access
Semantic Scholar
A venetoclax and azacitidine bridge‐to‐transplant strategy for NPM1‐mutated acute myeloid leukaemia in molecular failure
C. Sartor, L. Brunetti, E. Audisio, A. Cignetti +15 more
2023British Journal of Haematology24 citations Open access
Semantic Scholar
Acute Myeloid Leukemia Mutations: Therapeutic Implications
C. Papayannidis, C. Sartor, G. Marconi, M. Fontana +5 more
2019International Journal of Molecular Sciences23 citations Open access
Semantic Scholar
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
L. Bertamini, J. Nanni, G. Marconi, M. Abbenante +12 more
2018BMC Cancer23 citations Open access
Semantic Scholar
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease
S. Kayser, C. Sartor, F. Giglio, A. Bruno +15 more
2023Haematologica21 citations Open access
Semantic Scholar
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study
N. Fracchiolla, M. Sciumè, C. Papayannidis, A. Vitale +27 more
2023Cancers14 citations Open access
Semantic Scholar
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant
C. Papayannidis, C. Sartor, A. Dominietto, E. Zappone +15 more
2021Hematological Oncology14 citations
Semantic Scholar
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents
C. Papayannidis, J. Nanni, G. Cristiano, G. Marconi +16 more
2022European Journal of Haematology11 citations Open access
Semantic Scholar
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
S. Parisi, L. Ruggeri, E. Dan, S. Rizzi +22 more
2022Frontiers in Immunology11 citations Open access
Semantic Scholar
Early Low-Dose Computed Tomography with Pulmonary Angiography to Improve the Early Diagnosis of Invasive Mould Disease in Patients with Haematological Malignancies: A Pilot Study.
M. Stanzani, C. Sassi, R. Lewis, C. Sartor +3 more
2021Journal of Infection11 citations Open access
Semantic Scholar
Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/ hypomethylating agents
S. Kayser, K. Sanber, G. Marconi, Agnese Mattei +17 more
2024Haematologica10 citations Open access
Semantic Scholar
Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission
A. Candoni, P. Chiusolo, D. Lazzarotto, C. Sartor +10 more
2024Cancers10 citations Open access
Semantic Scholar
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia
F. Ravaioli, G. Marconi, G. Martinelli, E. Dajti +17 more
2021Cancer Medicine9 citations Open access
Semantic Scholar
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases
I. Vigliotta, S. Armuzzi, Martina Barone, V. Solli +18 more
2022Frontiers in Oncology8 citations Open access
Semantic Scholar
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia
G. Marconi, A. Talami, M. Abbenante, C. Sartor +22 more
2020European Journal of Haematology8 citations Open access
Semantic Scholar
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted
M. Mancini, C. Monaldi, S. De Santis, C. Papayannidis +12 more
2023Biomarker Research6 citations Open access
Semantic Scholar
Next‐generation sequencing improves BCR‐ABL1 mutation detection in Philadelphia chromosome‐positive acute lymphoblastic leukaemia
S. Soverini, M. Martelli, L. Bavaro, C. De Benedittis +22 more
2021British Journal of Haematology6 citations Open access
Semantic Scholar
Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients
P. E. Coppola, P. Gaibani, C. Sartor, S. Ambretti +9 more
2020Microorganisms6 citations Open access
Semantic Scholar
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia
S. Bruno, L. Bandini, A. Patuelli, V. Robustelli +16 more
2021Frontiers in Oncology5 citations Open access
Semantic Scholar
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients.
G. Marconi, Stefano de Polo, G. Martinelli, J. Nanni +19 more
2020Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis5 citations Open access
Semantic Scholar
INO‐CD22: A multicenter, real‐world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia
C. Papayannidis, E. Petracci, P. Zappasodi, N. Fracchiolla +29 more
2025Cancer4 citations Open access
Semantic Scholar
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment
C. Sartor, M. Arpinati, G. Chirumbolo, L. Dozza +13 more
2022Hematological Oncology4 citations
Semantic Scholar
The concomitant loss of APC and HNF4α in adult hepatocytes does not contribute to hepatocarcinogenesis driven by β-catenin activation
C. Sartor, L. Bachelot, C. Godard, F. Lager +5 more
2019Liver international (Print)4 citations Open access
Semantic Scholar
Mitoxantrone, Etoposide and Cytarabine (MEC) Can Induce Deep Complete Remission and Is an Effective Bridge Therapy to Allotransplantation (SCT) in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
G. Marconi, A. Talami, M. Abbenante, S. Paolini +16 more
2018Blood4 citations Open access
Semantic Scholar
Venetoclax and Azacitidine for Relapse Prevention in NPM1-Mutated Acute Myeloid Leukemia in Molecular Failure: Results from the Ongoing Gimema AML2521 Phase 2 Trial
C. Sartor, A. Candoni, A. Piciocchi, G. Marsili +23 more
2024Blood3 citations Open access
Semantic Scholar
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study
G. Marconi, A. Candoni, Roberta di Nicola, C. Sartor +21 more
2023Cancer Medicine3 citations Open access
Semantic Scholar
Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia
G. Marconi, A. Piciocchi, E. Audisio, G. Priolo +29 more
2022Blood3 citations Open access
Semantic Scholar
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia
S. Bruno, M. Bochicchio, E. Franchini, A. Padella +17 more
2019Journal of Oncology3 citations Open access
Semantic Scholar
A Chemo-Free Bridge-to-Transplant Strategy with Venetoclax and Azacitidine for NPM1-Mutated Acute Myeloid Leukemia in Molecular Failure
C. Sartor, L. Brunetti, E. Audisio, A. Cignetti +13 more
2022Blood2 citations
Semantic Scholar
Combined Inhibition of Polo-Like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells
M. Mancini, C. Monaldi, S. De Santis, M. Rondoni +6 more
2022Cancers2 citations Open access
Semantic Scholar
An Outpatient Management for First Cycle of Venetoclax and Hypomethylating Agents Results in Reduced Infection Rate and Hospitalizations in Acute Myeloid Leukemia Patients
J. Nanni, C. Papayannidis, G. Cristiano, G. Marconi +14 more
2021Blood2 citations Open access
Semantic Scholar
Outcome after Inotuzumab Ozogamicin for Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia and Extramedullary Disease
S. Kayser, C. Sartor, Marlise R. Luskin, Jonathan A. Webster +10 more
2021Blood2 citations Open access
Semantic Scholar
Blinatumomab and Inotuzumab for the Treatment of Multiply Relapsed Acute Lymphoblastic Leukemia: A Real-Life Campus ALL Study
M. Sciumè, C. Papayannidis, A. Curti, A. Vitale +25 more
2021Blood2 citations Open access
Semantic Scholar
Quantitative Assessment of Indoleamine 2,3-Dioxygenase (IDO) Expression at Diagnosis Predicts Clinical Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
S. Parisi, S. Ragaini, D. Ocadlikova, Mariangela Lecciso +10 more
2018Blood2 citations
Semantic Scholar
Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib
F. Angotzi, E. Borlenghi, C. Sartor, M. B. Giannini +13 more
2026Haematologica1 citations Open access
Semantic Scholar
Characteristics and Outcomes of Progressive Multifocal Leukoencephalopathy in Hematologic Malignancies: A SEIFEM Retrospective Review
D. Facchinelli, Linda Mazzai, F. Marchesi, F. Angotzi +17 more
2026American journal of hematology/oncology1 citations
Semantic Scholar
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
M. Sciumè, F. Serpenti, R. Zanotti, P. Bonadonna +18 more
2024Hematological Oncology1 citations
Semantic Scholar
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group
F. Forghieri, F. Bettelli, Simona Sgromo, G. Nadali +28 more
2024Annals of Hematology1 citations
Semantic Scholar
Optimizing Molecular Diagnosis of Systemic Mastocytosis in the Era of KIT Tyrosine Kinase Inhibitors: Results of a Survey and of a Nationwide Proficiency Control Round of KIT D816V Mutation Testing Promoted By the RIMA (Rete Italiana MAstocitosi) Association
S. Soverini, C. Monaldi, S. De Santis, M. Mancini +32 more
2024Blood1 citations
Semantic Scholar
PB1858: PROGNOSIS AND TREATMENT OF FLT3 MUTATED MYELOID SARCOMA IN THE ERA OF FLT3 INHIBITORS: RETROSPECTIVE EVALUATION IN 5 ITALIAN CENTERS.
Federica Lessi, E. Borlenghi, C. Sartor, C. Vetro +7 more
2023HemaSphere1 citations Open access
Semantic Scholar
T Cell/Natural Killer (NK) Cell Transcriptional Profiles Are Associated with Response to Gilteritinib in FLT3-Mutated Acute Myeloid Leukemia
J. Nanni, Jayakumar Vadakekolathu, L. Bandini, S. Bruno +21 more
2023Blood1 citations
Semantic Scholar
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis.
C. Monaldi, S. De Santis, M. Mancini, C. Papayannidis +5 more
2022Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Papayannidis×42
Invite
C. Papayannidis — researcher profile on SciRah
G. Marconi×25
Invite
G. Marconi — researcher profile on SciRah
M. Cavo×25
Invite
M. Cavo — researcher profile on SciRah
A. Curti×23
Invite
A. Curti — researcher profile on SciRah

×22

Invite

S. Paolini — researcher profile on SciRah

Invite

J. Nanni — researcher profile on SciRah

Invite

S. Parisi — researcher profile on SciRah

G. Cristiano×16

Invite

G. Cristiano — researcher profile on SciRah

G. Martinelli×14

Invite

G. Martinelli — researcher profile on SciRah

E. Ottaviani×14

Invite

E. Ottaviani — researcher profile on SciRah

S. Soverini×12

Invite

S. Soverini — researcher profile on SciRah

M. Abbenante×12

Invite

M. Abbenante — researcher profile on SciRah